Treatment of Invasive Aspergillosis (IA) in Pediatric Patients (Pts) with Micafungin (MICA) Alone or in Combination with Other Systemic Antifungal Agents.

P. M. FLYNN1, N. SEIBEL 2, A. ARRIETA 3, D. FACKLAM 4, L. KOVANDA 5, W. LAU 5, D. BUELL 5, D. W. DENNING 6;

Author address: 

1St. Jude Children's Res. Hosp., Memphis, TN, 2Children’s Natl. Med. Ctr., Washington, DC, 3Children’s Hosp. of Orange County, Los Angeles, CA, 4Astellas Pharma US, Inc, Chicago, IL, 5Astellas Pharma US, Inc., Chicago, IL, 6Univ. of Manchester, Manch

Abstract: 

Background: Experience with an echinocandin alone or in combination with another systemic antifungal agent in pediatrics is limited. Methods: A multinational, noncomparative study was conducted to evaluate the activity of MICA alone or in combination with other agents in the treatment of IA. Pediatric pts (
2006

abstract No: 

M-891

Full conference title: 

46th Interscience Conference on Antimicrobial Agents and Chemotherapy
    • ICAAC 46th